AzTrials
AzTrials

Rupture of Anterior Cruciate LigamentNCT00971451

Quadriceps Function Prior to Anterior Cruciate Ligament Reconstruction

A study testing cryotherapy and TENS in people with Rupture of Anterior Cruciate Ligament, run by University of Virginia at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Patients who are diagnosed with an isolated tear of the anterior cruciate ligament and scheduled for arthroscopic reconstruction using bone-patellar tendon-bone autograft will be recruited to participate. All subjects will be invited to participate in 2 weeks (2 supervised sessions per week) prior to their surgery. Read more about this study

Who is it for?
Ages 15 to 55 years
Conditions the study is for
Rupture of Anterior Cruciate Ligament
What is being tested?
cryotherapy and TENS
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteUnited States
Study dates
Nov 2007to Dec 2011
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 15 to 55 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • Complete ACL rupture
  • Age 15-55

Who cannot join

  • Persons who cannot tolerate knee joint TENS.
  • Persons who have a known allergy to cryotherapy
  • Patients who are pregnant or who plan on getting pregnant during the 12-month follow-up period.

Trial locations and contacts

1 site in 1 country.

United States1 site, 1 recruiting
  • University of Virginia

    Charlottesville, Virginia, 22908

    Joseph M Hart, PhD, 434-243-0256, jmh3zf@virginia.edu

    Joseph M Hart, Ph.D.

    Recruiting

Other trials in United States

About this study

Patients who are diagnosed with an isolated tear of the anterior cruciate ligament and scheduled for arthroscopic reconstruction using bone-patellar tendon-bone autograft will be recruited to participate.

All subjects will be invited to participate in 2 weeks (2 supervised sessions per week) prior to their surgery. Each session will include supervised therapeutic exercises. Subjects will be randomly assigned to receive continuous transcutaneous electrical nerve stimulation (TENS) during each session or knee joint cryotherapy prior to each exercise session. The investigators will measure quadriceps function before and after this 2-week intervention (both sessions occur prior to reconstruction surgery). This study will also have a true control group that will not receive either exercise of modality intervention. The investigators will collect subjective and objective outcomes data at regularly scheduled post-operative visits.

Being tested
cryotherapy, TENS
Keywords
Anterior cruciate ligament, ACL
Medical subject headings
Anterior Cruciate Ligament Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • cryotherapyOther

    20 minutes of knee joint cryotherapy - ice bag application

  • TENSOther

    continuous use of TENS during the exercise session

Study groups in NCT00971451
Study groupRoleWhat they receive
knee joint cryotherapyExperimental20 minutes of knee joint cryotherapy - ice bag application
Receives: Other: cryotherapy
TENSExperimentalcontinuous TENS for duration of the 1 hour exercise session
Receives: Other: TENS
No interventionNo interventionno modality intervention; just exercise

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Quadriceps muscle strength and inhibition using the quadriceps central activation ratio

    Measured: Day 15

Secondary outcomes (4)
  1. Quadriceps H-reflex testing

    Measured: Day 15

  2. International Knee Documentation Committee Subjective Knee Joint Evaluation

    Measured: Day 15

  3. Visual Analog Scale

    Measured: Day 15

  4. Tegner Activity Rating

    Measured: Day 15

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Sep 2009 (estimated)
  2. Study startNov 2007
  3. Primary completionDec 2011 (estimated)
  4. Study completionDec 2011 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00971451
Sponsor's protocol ID
13398
Status last verified
Mar 2011
First submitted
2 Sep 2009
Last updated
8 Mar 2011
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing cryotherapy and TENS in people with Rupture of Anterior Cruciate Ligament, run by University of Virginia at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 8 Mar 2011. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Joseph M Hart, Ph.D. (434-243-0256, jmh3zf@hscmail.mcc.virginia.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Quadriceps muscle strength and inhibition using the quadriceps central activation ratio (time frame: Day 15). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Mar 2011; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in